Literature DB >> 21614587

Dysmorphogenesis of lymph nodes in Foxc2 haploinsufficient mice.

Hiroshi Shimoda1, Michael J Bernas, Marlys H Witte.   

Abstract

Dysmorphogenesis of lymph nodes displayed in a fork head transcription factor Foxc2 haploinsufficient mice--a model for lymphedema-distichiasis syndrome--was studied by immunohistochemistry and electron microscopy. The Foxc2 heterozygous mice manifested lymph node hyperplasia composed of conspicuous proliferation of endothelial cells forming the lymphatic sinus and α-smooth muscle actin (SMA)-immunopositive fibroblast-like cells in the lymphatic pulp, particularly around the sinus. The hyperplastic sinus endothelial cells and the SMA-positive cells demonstrated distinct immunolocalization of platelet-derived growth factor (PDGF)-B, a crucial chemoattractant for vascular mural cell recruitment, and its receptor, PDGFR-β, respectively. The observations suggest that the sinus endothelial cells elicit abnormal recruitment of the fibroblast-like cells as a type of vascular mural cells via PDGF-B/PDGFR-β signaling in lymph nodes of the Foxc2 heterozygotes. Furthermore, in Foxc2 heterozygous lymph nodes, recruited SMA-positive cells displayed an intense immunoreaction for vascular endothelial growth factor (VEGF)-C, a highly specific lymphangiogenic factor, and its receptor, VEGFR-3, was preferentially distributed in the lymphatic sinus endothelial cells. These findings suggest that an interactive cycle between lymphatic sinus endothelial cells and the fibroblast-like cells, which involves PDGF-B/PDGFR-β and VEGF-C/VEGFR-3 signaling, is essential for aberrant hyperplasia of the lymphatic sinus and the fibroblast-like cells in Foxc2 haploinsufficiency.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21614587     DOI: 10.1007/s00418-011-0819-x

Source DB:  PubMed          Journal:  Histochem Cell Biol        ISSN: 0948-6143            Impact factor:   4.304


  32 in total

Review 1.  Forkhead transcription factors: key players in development and metabolism.

Authors:  Peter Carlsson; Margit Mahlapuu
Journal:  Dev Biol       Date:  2002-10-01       Impact factor: 3.582

2.  Comparative lymphatic, ocular, and metabolic phenotypes of Foxc2 haploinsufficient and aP2-FOXC2 transgenic mice.

Authors:  A Noon; R J Hunter; M H Witte; B Kriederman; M Bernas; M Rennels; D Percy; S Enerbäck; R P Erickson
Journal:  Lymphology       Date:  2006-06       Impact factor: 1.286

3.  Pericyte loss and microaneurysm formation in PDGF-B-deficient mice.

Authors:  P Lindahl; B R Johansson; P Levéen; C Betsholtz
Journal:  Science       Date:  1997-07-11       Impact factor: 47.728

4.  MFH-1, a new member of the fork head domain family, is expressed in developing mesenchyme.

Authors:  N Miura; A Wanaka; M Tohyama; K Tanaka
Journal:  FEBS Lett       Date:  1993-07-12       Impact factor: 4.124

5.  Truncating mutations in FOXC2 cause multiple lymphedema syndromes.

Authors:  D N Finegold; M A Kimak; E C Lawrence; K L Levinson; E M Cherniske; B R Pober; J W Dunlap; R E Ferrell
Journal:  Hum Mol Genet       Date:  2001-05-15       Impact factor: 6.150

6.  Roles of forkhead transcription factor Foxc2 (MFH-1) and endothelin receptor A in cardiovascular morphogenesis.

Authors:  Naoko Kanzaki-Kato; Tomoki Tamakoshi; Yan Fu; Abhishek Chandra; Tatsuo Itakura; Tadayoshi Uezato; Toshinobu Tanaka; David E Clouthier; Toshihiro Sugiyama; Masashi Yanagisawa; Naoyuki Miura
Journal:  Cardiovasc Res       Date:  2005-02-15       Impact factor: 10.787

7.  The forkhead transcription factors, Foxc1 and Foxc2, are required for arterial specification and lymphatic sprouting during vascular development.

Authors:  Seungwoon Seo; Hideo Fujita; Atsushi Nakano; Myengmo Kang; Antonio Duarte; Tsutomu Kume
Journal:  Dev Biol       Date:  2006-04-03       Impact factor: 3.582

8.  PDGF-B signaling is important for murine cardiac development: its role in developing atrioventricular valves, coronaries, and cardiac innervation.

Authors:  Nynke M S Van den Akker; Leah C J Winkel; Maya H Nisancioglu; Saskia Maas; Lambertus J Wisse; Annika Armulik; Robert E Poelmann; Heleen Lie-Venema; Christer Betsholtz; Adriana C Gittenberger-de Groot
Journal:  Dev Dyn       Date:  2008-02       Impact factor: 3.780

9.  Analysis of the phenotypic abnormalities in lymphoedema-distichiasis syndrome in 74 patients with FOXC2 mutations or linkage to 16q24.

Authors:  G Brice; S Mansour; R Bell; J R O Collin; A H Child; A F Brady; M Sarfarazi; K G Burnand; S Jeffery; P Mortimer; V A Murday
Journal:  J Med Genet       Date:  2002-07       Impact factor: 6.318

10.  Paracrine PDGF-B/PDGF-Rbeta signaling controls mesangial cell development in kidney glomeruli.

Authors:  P Lindahl; M Hellström; M Kalén; L Karlsson; M Pekny; M Pekna; P Soriano; C Betsholtz
Journal:  Development       Date:  1998-09       Impact factor: 6.868

View more
  6 in total

Review 1.  Recent progress in histochemistry and cell biology.

Authors:  Stefan Hübner; Athina Efthymiadis
Journal:  Histochem Cell Biol       Date:  2012-02-25       Impact factor: 4.304

2.  Combining Foxc2 and Connexin37 deletions in mice leads to severe defects in lymphatic vascular growth and remodeling.

Authors:  John D Kanady; Stephanie J Munger; Marlys H Witte; Alexander M Simon
Journal:  Dev Biol       Date:  2015-06-14       Impact factor: 3.582

3.  Mutations in the VEGFR3 signaling pathway explain 36% of familial lymphedema.

Authors:  A Mendola; M J Schlögel; A Ghalamkarpour; A Irrthum; H L Nguyen; E Fastré; A Bygum; C van der Vleuten; C Fagerberg; E Baselga; I Quere; J B Mulliken; L M Boon; P Brouillard; M Vikkula
Journal:  Mol Syndromol       Date:  2013-08-21

4.  Interleukin-8 reduces post-surgical lymphedema formation by promoting lymphatic vessel regeneration.

Authors:  Inho Choi; Yong Suk Lee; Hee Kyoung Chung; Dongwon Choi; Tatiana Ecoiffier; Ha Neul Lee; Kyu Eui Kim; Sunju Lee; Eun Kyung Park; Yong Sun Maeng; Nam Yun Kim; Robert D Ladner; Nicos A Petasis; Chester J Koh; Lu Chen; Heinz-Josef Lenz; Young-Kwon Hong
Journal:  Angiogenesis       Date:  2012-09-04       Impact factor: 9.596

5.  FOXC2 controls adult lymphatic endothelial specialization, function, and gut lymphatic barrier preventing multiorgan failure.

Authors:  Alejandra González-Loyola; Esther Bovay; Jaeryung Kim; Tania Wyss Lozano; Amélie Sabine; Francois Renevey; Silvia Arroz-Madeira; Alexis Rapin; Tomasz P Wypych; Giorgia Rota; Stephan Durot; Dominique Velin; Benjamin Marsland; Greta Guarda; Mauro Delorenzi; Nicola Zamboni; Sanjiv A Luther; Tatiana V Petrova
Journal:  Sci Adv       Date:  2021-07-16       Impact factor: 14.136

6.  A Novel Mutation in the FOXC2 Gene: A Heterozygous Insertion of Adenosine (c.867insA) in a Family with Lymphoedema of Lower Limbs without Distichiasis.

Authors:  Tanja Planinsek Rucigaj; Matija Rijavec; Jovan Miljkovic; Julij Selb; Peter Korosec
Journal:  Radiol Oncol       Date:  2017-07-06       Impact factor: 2.991

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.